Medical Oncology

Susan Faye Dent, MD

Instructor in the Department of Medicine
Member of the Duke Cancer Institute
Campus mail 10 Bryan Searle Drive, Seeley G Mudd Building, Rm 455, DUMC 3446, Durham, NC 27710
Phone (919) 684-5734
Email address susan.dent@duke.edu

Medical Oncologist with a focus on breast cancer
Associate Director of Breast Cancer Clinical Research
Co-Director Duke Cardio-Oncology Program

Education and Training

  • Medical Oncology, Royal College of Physicians (UK), 1993 - 1995
  • Internal Medicine, Royal College of Physicians (UK), 1990 - 1993
  • M.D., McMaster University, 1990

Grants

Publications

Dent, Susan, Chiara Melloni, Josee Ivars, Sarah Sammons, and Gretchen Kimmick. “Cardiotoxicities of Modern Treatments in Breast Cancer..” Curr Treat Options Cardiovasc Med 21, no. 7 (June 15, 2019). https://doi.org/10.1007/s11936-019-0738-z.

PMID
31203459
Full Text

Kimmick, Gretchen, Susan Dent, and Igor Klem. “Risk of Cardiomyopathy in Breast Cancer: How Can We Attenuate the Risk of Heart Failure from Anthracyclines and Anti-HER2 Therapies?.” Curr Treat Options Cardiovasc Med 21, no. 6 (May 31, 2019). https://doi.org/10.1007/s11936-019-0736-1.

PMID
31152324
Full Text

Dent, S., C. Ammendolea, A. Christofides, S. Edwards, D. Incekol, B. Pourmirza, S. Kfoury, and B. Poirier. “A multidisciplinary perspective on the subcutaneous administration of trastuzumab in HER2-positive breast cancer..” Curr Oncol 26, no. 1 (February 2019): e70–80. https://doi.org/10.3747/co.26.4220.

PMID
30853812
Full Text

Khouri, M. G., I. Klem, C. Shenoy, J. Sulpher, and S. F. Dent. “Screening and monitoring for cardiotoxicity during cancer treatment.” In Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease, 43–80, 2017. https://doi.org/10.1007/978-3-319-43096-6_3.

Full Text

Armenian, Saro H., Christina Lacchetti, Ana Barac, Joseph Carver, Louis S. Constine, Neelima Denduluri, Susan Dent, et al. “Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline..” J Clin Oncol 35, no. 8 (March 10, 2017): 893–911. https://doi.org/10.1200/JCO.2016.70.5400.

PMID
27918725
Full Text

Lenihan, Daniel J., Gregory Hartlage, Jeanne DeCara, Anne Blaes, J Emanuel Finet, Alexander R. Lyon, Robert F. Cornell, et al. “Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty..” J Card Fail 22, no. 6 (June 2016): 465–71. https://doi.org/10.1016/j.cardfail.2016.03.012.

PMID
27038642
Full Text

Brackstone, M., G. G. Fletcher, I. S. Dayes, Y. Madarnas, S. K. Sen Gupta, S. Verma, A. Eisen, et al. “Locoregional therapy of locally advanced breast cancer: A clinical practice guideline.” Current Oncology 22 (March 1, 2015): S54–66. https://doi.org/10.3747/co.22.2316.

Full Text

Eisen, A., G. G. Fletcher, S. Gandhi, M. Mates, O. C. Freedman, S. F. Dent, M. E. Trudeau, and M. E. members of the Early Breast Cancer Systemic Therapy Consensus Panel. “Optimal systemic therapy for early breast cancer in women: a clinical practice guideline..” Curr Oncol 22, no. Suppl 1 (March 2015): S67–81. https://doi.org/10.3747/co.22.2320.

PMID
25848340
Full Text

Mates, M., G. G. Fletcher, O. C. Freedman, A. Eisen, S. Gandhi, M. E. Trudeau, and S. F. Dent. “Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline..” Curr Oncol 22, no. Suppl 1 (March 2015): S114–22. https://doi.org/10.3747/co.22.2322.

PMID
25848335
Full Text

Freedman, O. C., G. G. Fletcher, S. Gandhi, M. Mates, S. F. Dent, M. E. Trudeau, and A. Eisen. “Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline..” Curr Oncol 22, no. Suppl 1 (March 2015): S95–113. https://doi.org/10.3747/co.22.2326.

PMID
25848344
Full Text

Pages